SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-23-000191
Filing Date
2023-02-14
Accepted
2023-02-14 17:16:03
Documents
2
Group Members
ORBIMED CAPITAL GP IX LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ss1758630_sc13g.htm SC 13G 48751
2 JOINT FILING AGREEMENT ss1758630_ex99a.htm EX-99.A 5258
  Complete submission text file 0000947871-23-000191.txt   55531
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G

Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Subject) CIK: 0001526119 (see all company filings)

IRS No.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86603 | Film No.: 23631607
SIC: 2834 Pharmaceutical Preparations